{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32919180",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "08",
        "Day": "27"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.msard.2020.102469",
      "S2211-0348(20)30544-7"
    ],
    "Journal": {
      "ISSN": "2211-0356",
      "JournalIssue": {
        "Volume": "46",
        "PubDate": {
          "Year": "2020",
          "Month": "Nov"
        }
      },
      "Title": "Multiple sclerosis and related disorders",
      "ISOAbbreviation": "Mult Scler Relat Disord"
    },
    "ArticleTitle": "Favorable outcomes after COVID-19 infection in multiple sclerosis patients treated with cladribine tablets.",
    "Pagination": {
      "StartPage": "102469",
      "MedlinePgn": "102469"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Merck KGaA, Darmstadt, Germany. Electronic address: dominic.jack@merckgroup.com."
          }
        ],
        "LastName": "Jack",
        "ForeName": "Dominic",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Merck KGaA, Darmstadt, Germany."
          }
        ],
        "LastName": "Nolting",
        "ForeName": "Axel",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Merck, Aubonne, Switzerland, a division of Merck KGaA, Darmstadt, Germany."
          }
        ],
        "LastName": "Galazka",
        "ForeName": "Andrew",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Letter",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Mult Scler Relat Disord",
    "NlmUniqueID": "101580247",
    "ISSNLinking": "2211-0348"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunosuppressive Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Tablets"
    },
    {
      "RegistryNumber": "47M74X9YT5",
      "NameOfSubstance": "Cladribine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "complications",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Cladribine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "adverse effects",
        "pharmacology"
      ],
      "DescriptorName": "Immunosuppressive Agents"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "virology"
      ],
      "DescriptorName": "Multiple Sclerosis"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Tablets"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "DJ and AN are employees of Merck KGaA, Darmstadt, Germany. AG is an employee of Merck, Aubonne, Switzerland, a division of Merck KGaA, Darmstadt, Germany."
}